Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

AsiaPharm Signs Deals with Two Scottish Pharmas

publication date: Apr 15, 2008

Two development stage Scottish pharmaceutical companies have signed deals with AsiaPharm. Under the agreements, AsiaPharm will seek to obtain SFDA approval for drugs from GlycoMar of Oban, Scotland, and from Scottish Biomedical of Glasgow. If AsiaPharm is successful in obtaining SFDA approval, AsiaPharm can license the marketing rights for the drugs. Financial details of the agreements were not disclosed. More details...

Stock Symbol: (SI: ASPH)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital